{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:49:28Z","timestamp":1770068968011,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ghir.2021.101442","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T12:27:15Z","timestamp":1639657635000},"page":"101442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["\u201cSubclinical atherosclerosis in acromegaly: Possible association with cardiovascular risk factors rather than disease activity\u201d"],"prefix":"10.1016","volume":"62","author":[{"given":"Maria Cristina Costa","family":"de Almeida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia Maria Vilas","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do Carmo P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Santana","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia M.","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Varella","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo Pereira","family":"Zille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Augusto Carvalho","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Antonio","family":"Ribeiro-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana Beaudette","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.ghir.2021.101442_bb0005","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: Acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ghir.2021.101442_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12020-014-0327-6","article-title":"GH and the cardiovascular system: an update on a topic at heart","volume":"48","author":"Isgaard","year":"2015","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ghir.2021.101442_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","article-title":"Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities","volume":"20","author":"Pivonello","year":"2017","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.ghir.2021.101442_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/EJE-13-1022","article-title":"Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)","volume":"171","author":"Colao","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2021.101442_bb0025","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"7","key":"10.1016\/j.ghir.2021.101442_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ncpendmet0222","article-title":"Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma","volume":"2","author":"Bonert","year":"2006","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2021.101442_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00005792-199409000-00001","article-title":"Clinical and biochemical features in 500 patients","volume":"73","author":"Ezzat","year":"1994","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1530\/eje.0.1510439","article-title":"Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly registry (Registro Espanol de Acromegalia, REA)","volume":"151","author":"Mestron","year":"2004","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4158\/EP.13.4.363","article-title":"Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly","volume":"13","author":"Vilar","year":"2007","journal-title":"Endocr. Pract."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11154-020-09560-x","article-title":"Acromegaly, inflammation and cardiovascular disease: a review","volume":"21","author":"Wolters","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0055","first-page":"1047","article-title":"Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?","volume":"82","author":"Lopez-Velasco","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ghir.2021.101442_bb0060","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jcmg.2013.11.014","article-title":"Carotid intima-media thickness and plaque in cardiovascular risk assessment","volume":"7","author":"Naqvi","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"2","key":"10.1016\/j.ghir.2021.101442_bb0065","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.atherosclerosis.2007.01.019","article-title":"Carotid atherosclerosis and vascular age in the assessment of coronary heart disease risk beyond the Framingham risk score","volume":"196","author":"Junyent","year":"2008","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ghir.2021.101442_bb0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1573403X12666160803095855","article-title":"Imaging subclinical atherosclerosis: where do we stand?","volume":"13","author":"Papageorgiou","year":"2017","journal-title":"Curr. Cardiol. Rev."},{"issue":"Suppl E","key":"10.1016\/j.ghir.2021.101442_bb0075","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1093\/eurheartj\/suaa068","article-title":"Subclinical atherosclerosis: how and when to treat it?","volume":"22","author":"Gatto","year":"2020","journal-title":"Eur. Heart J. Suppl."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0080","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ghir.2021.101442_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2011.06.044","article-title":"Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis","volume":"220","author":"Inaba","year":"2012","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ghir.2021.101442_bb0090","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/jc.2010-2225","article-title":"Changes in arterial stiffness but not carotid intimal thickness in acromegaly","volume":"96","author":"Paisley","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ghir.2021.101442_bb0095","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jcem.87.7.8573","article-title":"Cardiovascular consequences of early-onset growth hormone excess","volume":"87","author":"Colao","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ghir.2021.101442_bb0100","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jcem.87.7.8643","article-title":"Early vascular alterations in acromegaly","volume":"87","author":"Brevetti","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2021.101442_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11102-016-0710-9","article-title":"Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors","volume":"19","author":"Yaron","year":"2016","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.ghir.2021.101442_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1742-1241.2008.01750.x","article-title":"Investigation of early atherosclerotic changes in acromegalic patients","volume":"64","author":"Kartal","year":"2010","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.ghir.2021.101442_bb0115","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1365-2265.2001.01281.x","article-title":"Characterization of premature atherosclerosis of carotid arteries in acromegalic patients","volume":"54","author":"Otsuki","year":"2001","journal-title":"Clin. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2021.101442_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11102-018-0911-5","article-title":"Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis","volume":"21","author":"Parolin","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2021.101442_bb0125","author":"CDC"},{"key":"10.1016\/j.ghir.2021.101442_bb0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3389\/fmed.2017.00231","article-title":"Techniques for non-invasive monitoring of arterial blood pressure","volume":"4","author":"Meidert","year":"2017","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.ghir.2021.101442_bb0135","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D\u2019Agostino","year":"2008","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ghir.2021.101442_bb0140","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.ghir.2021.101442_bb0145","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0004-27302010000500008","article-title":"Normal values of serum IGF-1 in adults: results from a Brazilian population","volume":"54","author":"Rosario","year":"2010","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"issue":"Pt 6","key":"10.1016\/j.ghir.2021.101442_bb0150","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1258\/acb.2008.008074","article-title":"Standardization of the IMMULITE systems growth hormone assay with the recombinant IS 98\/574","volume":"45","author":"Barth","year":"2008","journal-title":"Ann. Clin. Biochem."},{"issue":"2","key":"10.1016\/j.ghir.2021.101442_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"Stein","year":"2008","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ghir.2021.101442_bb0160","first-page":"811","article-title":"Comparison between automated and manual measurements of carotid intima-media thickness in clinical practice","volume":"5","author":"Freire","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"issue":"1","key":"10.1016\/j.ghir.2021.101442_bb0165","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc. Dis."},{"issue":"12","key":"10.1016\/j.ghir.2021.101442_bb0170","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/archinte.168.12.1333","article-title":"Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the multi-ethnic study of atherosclerosis (MESA)","volume":"168","author":"Folsom","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"10.1016\/j.ghir.2021.101442_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017063","article-title":"The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected","volume":"6","author":"Pena","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ghir.2021.101442_bb0180","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/a-1247-4713","article-title":"Multicenter, observational study of lanreotide autogel for the treatment of patients with acromegaly in routine clinical practice in Germany, Austria and Switzerland","volume":"129","author":"Stormann","year":"2021","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: a consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"9","key":"10.1016\/j.ghir.2021.101442_bb0190","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.ghir.2021.101442_bb0195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP161637.OR","article-title":"Assessment of diastolic dysfunction, arterial stiffness, and carotid intima-media thickness in patients with acromegaly","volume":"23","author":"Cansu","year":"2017","journal-title":"Endocr. Pract."},{"issue":"9","key":"10.1016\/j.ghir.2021.101442_bb0200","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF03346667","article-title":"The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues","volume":"33","author":"De Martino","year":"2010","journal-title":"J. Endocrinol. Investig."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0205","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2001.01256.x","article-title":"Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly","volume":"54","author":"Colao","year":"2001","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2021.101442_bb0210","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1530\/eje.0.1460303","article-title":"Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly","volume":"146","author":"Colao","year":"2002","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0215","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0032-1304606","article-title":"Structural and functional changes of carotid wall properties in patients with acromegaly are not restored after 1 year of GH\/IGF1 normalization","volume":"120","author":"Galoiu","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0220","doi-asserted-by":"crossref","first-page":"379","DOI":"10.33549\/physiolres.930251","article-title":"The relationship between the IGF-I system and its binding proteins and microvascular reactivity in type 1 diabetes mellitus","volume":"51","author":"Krsek","year":"2002","journal-title":"Physiol. Res."},{"issue":"3","key":"10.1016\/j.ghir.2021.101442_bb0225","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11102-011-0327-y","article-title":"Procalcitonin can be used as a marker of premature atherosclerosis in acromegaly","volume":"15","author":"Ozkan","year":"2012","journal-title":"Pituitary"},{"issue":"Pt 4","key":"10.1016\/j.ghir.2021.101442_bb0230","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0004563214562431","article-title":"Relationship of apelin, procalcitonin, and fetuin-a concentrations with carotid intima-media thickness in acromegaly","volume":"52","author":"Topsakal","year":"2015","journal-title":"Ann. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.ghir.2021.101442_bb0235","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz096","article-title":"A consensus on the diagnosis and treatment of Acromegaly comorbidities: an update","volume":"105","author":"Giustina","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.ghir.2021.101442_bb0240","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2265.2012.04361.x","article-title":"Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly","volume":"77","author":"Lin","year":"2012","journal-title":"Clin. Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637421000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:52:25Z","timestamp":1761087145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637421000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":48,"alternative-id":["S1096637421000654"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101442","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cSubclinical atherosclerosis in acromegaly: Possible association with cardiovascular risk factors rather than disease activity\u201d","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2021.101442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101442"}}